1. Particulate Matter in Injectable Drug Products;Langille;PDA J Pharm Sci Technol,2013
2. Effects of protein aggregates: an immunologic perspective;Rosenberg;AAPS J,2006
3. The potential clinical relevance of visible particles in parenteral drugs;Doessegger;J Pharm Sci,2012
4. USP<1787>- Measurement of subvisible particulate matter in therapeutic protein injections.
5. USP<1788>- Methods for the determination of subvisible particulate matter.